[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

About this update from Illumina, Inc.

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Targeted DNA RNA Sequencing Market size & share revenue was valued at approximately USD 8.6 Billion in 2025 and is expected to reach USD 10.2 Billion in 2026 and is expected to reach around USD 46.9 Billion by 2035, at a CAGR of 18.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Illumina, F. Hoffman-La Roche Ltd., QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Oxford Nanopore Technologies, PierianDx, Genomatix GmbH, DNASTAR Inc., Perkin Elmer Inc. and others. Austin, TX, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Targeted DNA RNA Sequencing Market Size, Trends and Insights By Technology (NGS, Method, Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing, Others, Application, Cancer Gene Sequencing, Inherited Disease Screening, Drug Development, Forensic Genomics, 16S ribosomal RNA (rRNA) sequencing, Others), By Workflow (Data Analysis, Pre-sequencing, Sequencing), By Application (Drug Discovery, Human Biomedical Research, Plant & Animal Sciences, Others), By Type (DNA Based Targeted Sequencing, RNA Based Targeted Sequencing), By End Use (Academic Research, Pharma & Biotech Entities, Hospitals & Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035” in its research database. According to the latest research study, the global Targeted DNA RNA Sequencing Market was valued at approximately USD 8.6 billion in 2025, is expected to reach USD 10.2 billion in 2026, and is projected to grow to around USD 46.9 billion by 2035, with a compound annual growth rate (CAGR) of about 18.5% during the forecast period from 2026 to 2035. Click Here to Access a Free Sample Report of the Global Targeted DNA RNA Sequencing Market @  https://www.healthcareforesights.com/request-customization?reportId=1058 Targeted DNA RNA Sequencing Market Revenue and Trends Targeted DNA and RNA sequencing uses a special next-generation sequencing method that allows researchers to study specific genetic materials, certain genomic areas, and known RNA molecules with clinical or biological value, rather than doing a full genomic or transcriptomic study. The method uses established DNA or RNA target selection methods through amplicon-based or hybrid-capture panel technologies to enrich selected genetic materials, which enables researchers to focus their sequencing efforts on the most valuable genomic areas. The method permits scientists to achieve deep sequencing coverage combined with strong detection abilities, which allow for precise identification of genetic alterations that include mutations and copy number changes and gene fusions and expression variations, even when working with minimal or substandard samples. Request a Customized Copy of the Targeted DNA RNA Sequencing Market Report @ https://www.healthcareforesights.com/request-sample?reportId=1058 What are the Factors That Have a Significant Contribution to the Growth of the Targeted DNA RNA Sequencing Market? The targeted DNA and RNA sequencing market grows because government organizations and health agencies require genomic data to monitor infectious diseases and track pathogen evolution and detect initial disease outbreaks. Testing facilities can use targeted sequencing panels to detect specific pathogens and their variants together with antimicrobial resistance indicators, which makes these panels suitable for use in routine surveillance operations. National genomics initiatives and better public health systems and knowledge from recent global health emergencies drive the progress of targeted DNA and RNA sequencing for continuous disease monitoring and community health assessment. Additionally, the targeted DNA and RNA sequencing market continues to grow because pharmaceutical and biotechnology companies use these technologies to discover biomarkers and confirm research targets and develop companion diagnostics. Targeting specific genomic sequences enables researchers to investigate essential medical genes and biological pathways, which supports the development of patient classification systems and clinical trial designs and treatment outcome assessments. The approach works best in translational research because scientists can use genomic discoveries for clinical applications, and the method gives results at lower costs and with high accuracy and reliability. (A free sample of the Targeted DNA RNA Sequencing report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Request a Customized Copy of the Targeted DNA RNA Sequencing Market Report @ https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market Segment Insight By Application The human biomedical research segment is growing at a significant rate over the projected period. The segment exists as the leading segment because academic researchers and clinical researchers now prefer targeted sequencing for their work in cancer genomics and rare disease research and biomarker discovery, combined with the rising funds allocated to precision medicine initiatives and large-scale genomic projects. Request a Customized Copy of the Targeted DNA RNA Sequencing Market Report @ https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market Key questions answered in this report: Key Offerings: Buy this Premium Targeted DNA RNA Sequencing Research Report | Fast Delivery Available - [220+ Pages] @  https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market Regional Insights North America held the highest market share in 2025. The revenue growth of the region is supported by three factors, which include the fast adoption of liquid biopsy-targeted sequencing technology and the active research and development work of pharmaceutical companies and biotechnology firms and the comprehensive clinical trial studies that use targeted genomic tests. North America has emerged as a key driver of worldwide market revenue because its leading sequencing technology providers and their growing reimbursement support for clinically validated NGS panels and their beneficial regulatory frameworks continue to drive market growth. Besides, the Asia Pacific market has the highest rate of growth in the  Targeted DNA RNA Sequencing market . The rising cancer rates and growing elderly population together with increased understanding of molecular testing for early cancer detection and specific treatment selection are driving greater demand from hospitals and diagnostic labs. This is expected to drive the regional market. Request a Customized Copy of the Targeted DNA RNA Sequencing Market Report @  https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market We customize your report to align with your specific research requirements. Inquire with our sales team about customizing your report.) Still Looking for More Information? Do you want data for inclusion in magazines, case studies, research papers, or media?  Email Directly Here with Detailed Information: [email protected] Browse the full  “Targeted DNA RNA Sequencing Market Size, Trends and Insights By Technology (NGS, Method, Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing, Others, Application, Cancer Gene Sequencing, Inherited Disease Screening, Drug Development, Forensic Genomics, 16S ribosomal RNA (rRNA) sequencing, Others), By Workflow (Data Analysis, Pre-sequencing, Sequencing), By Application (Drug Discovery, Human Biomedical Research, Plant & Animal Sciences, Others), By Type (DNA Based Targeted Sequencing, RNA Based Targeted Sequencing), By End Use (Academic Research, Pharma & Biotech Entities, Hospitals & Clinics, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2026 – 2035”  Report at  https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market Report Scope Recent Developments Click Here to Access a Free Sample Report of the Global Targeted DNA RNA Sequencing Market @  https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market Spectacular Deals Browse More Related Reports: In Silico Clinical Trials Market Bioprocess Digital Twin Market Cell Therapy Human Raw Materials Market US Viral Vector and Plasmid DNA Manufacturing Market US Microcarriers Market US Biobanks Market Stem Cell Culture Media Market Next Generation Sequencing Services Market Genome Editing Market List of the prominent players in the Targeted DNA RNA Sequencing Market : The  Targeted DNA RNA Sequencing Market  is segmented as follows: By Technology By Workflow By Application By Type By End Use Click Here to Get a Free Sample Report of the Global Targeted DNA RNA Sequencing Market @ https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market Regional Coverage: North America Europe Asia Pacific The Middle East & Africa Latin America This Targeted DNA RNA Sequencing Market Research/Analysis Report Contains Answers to the following Questions . Click Here to Access a Free Sample Report of the Global Targeted DNA RNA Sequencing Market @  https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market Reasons to Purchase Targeted DNA RNA Sequencing Market Report Reasons for the Research Report Buy this Premium Targeted DNA RNA Sequencing Research Report | Fast Delivery Available - [220+ Pages] @  https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market What does the report include? Who should buy this report? Request a Customized Copy of the Targeted DNA RNA Sequencing Market Report @ https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market About Healthcare Foresights: Healthcare Foresights  is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. Healthcare Foresights is a one-stop solution for data collection and investment advice. Our company's expert analysis digs out essential factors that help us understand the significance and impact of market dynamics. The professional experts advise clients on aspects such as strategies for future estimation, forecasting, opportunities to grow, and consumer surveys. Follow Us:  LinkedIn | Twitter | Facebook | Instagram Contact Us: Frank Gittens CMI Consulting LLC 701 Tillery Street Unit 12-1333 Austin, Texas 78702 United States USA: +1 737-734-2707 APAC: +91 20 46022736 WhatsApp No : +1 801 639 9061 Email:  [email protected] Blog: https://www.healthcareforesights.com/ Buy this Premium Targeted DNA RNA Sequencing Research Report | Fast Delivery Available - [220+ Pages] @  https://www.healthcareforesights.com/reports/targeted-dna-rna-sequencing-market

View stock analysis, news, and events for Illumina, Inc.